Market revenue in 2023 | USD 81.5 million |
Market revenue in 2030 | USD 138.5 million |
Growth rate | 7.9% (CAGR from 2023 to 2030) |
Largest segment | Logistics & distribution |
Fastest growing segment | Logistics & distribution |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Logistics & distribution, Storage & retention, Packaging, labeling and blinding, Manufacturing, Comparator sourcing, Other services (solutions, ancillary supply) |
Key market players worldwide | Thermo Fisher Scientific Inc, Catalent Inc, PAREXEL, Almac Group, Piramal Pharma Solutions, DHL Group, FedEx Corp, UDG Healthcare, Marken, Walden Group, PCI Pharma Services |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to clinical trial supply & logistics market will help companies and investors design strategic landscapes.
Logistics & distribution was the largest segment with a revenue share of 25.4% in 2023. Horizon Databook has segmented the Australia clinical trial supply & logistics market based on logistics & distribution, storage & retention, packaging, labeling and blinding, manufacturing, comparator sourcing, other services (solutions, ancillary supply) covering the revenue growth of each sub-segment from 2018 to 2030.
The country is one of the fastest growing countries in terms of conducting clinical trials. Around 8,180 clinical trial research were registered in the U.S. clinical trial database by June 2021 (with Australian sites involved).
With a population of around 25 million individuals, the country has a high number of high-quality clinical sites, which allows fast enrollment in clinical studies. Main cities in Australia centralizing clinical trials include Melbourne, Sydney, and Brisbane.
Furthermore, growing government support is anticipated to attract biopharmaceutical companies to conduct trials and promote entry of clinical trial supply and logistics players. These factors are expected to contribute to growth of Australia clinical trial supply and logistics market.
Horizon Databook provides a detailed overview of country-level data and insights on the Australia clinical trial supply & logistics market , including forecasts for subscribers. This country databook contains high-level insights into Australia clinical trial supply & logistics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account